人类脂肪衍生的干细胞被遗传编程以诱导癌症免疫疗法癌症亡
Soyeon Bak1,2, Kyoung Sub Kim1, Kun Na3,4
1Department of Biomedical-Chemical Engineering, The Catholic University of Korea, 43 Jibong-ro, Wonmi-gu, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.
Cancer gene therapy
|June 10, 2024
概括
工程干细胞诱导亡,一个被编程的细胞死亡,触发对瘤的免疫反应. 这种新的方法通过刺激细胞毒性T细胞,显示出有效的抗癌免疫疗法的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 干细胞生物学 干细胞生物学
背景情况:
- 亡,一种编程细胞死亡的形式,释放与损伤相关的分子模式,可以启动免疫反应.
- 这种免疫反应在开发有效的抗癌免疫疗法方面具有潜在的应用.
研究的目的:
- 研究人类脂肪衍生干细胞 (ADSCs) 的潜力,这些干细胞被设计为表达受体相互作用蛋白激酶-3 (RIP3) 用于瘤免疫治疗.
- 评估这些工程细胞 (RP@ADSCs) 的抗癌作用和免疫刺激能力.
主要方法:
- 人类ADSCs被基因改造以表达RIP3基因,从而产生RP@ADSCs.
- 在注射后,RP@ADSCs被编程为体内亡.
- 这项研究涉及对质母细胞瘤 (GL-26) 和黑色素瘤 (K1735) 的小鼠模型中的RP@ADSCs进行评估.
主要成果:
- 证实了RIP3蛋白表达在ADSCs转染后的增加.
- RP@ADSCs诱导细胞死亡长达7天,释放促炎细胞因子.
- 在瘤模型中,使用RP@ADSCs的治疗导致长期细胞毒性T细胞数量增加,调节性T细胞数量减少.
结论:
- 诱导亡的工程ADSCs (RP@ADSCs) 能够有效地刺激抗癌免疫反应.
- RP@ADSCs显示出作为临床抗癌免疫疗法的可行药物潜力.
相关概念视频
Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K


